In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 89364-31-8, name is Tetrahydrofuran-3-carboxylic acid, introducing its new discovery. Recommanded Product: Tetrahydrofuran-3-carboxylic acid
3-SUBSTITUTED PYRAZOLES AND USE AS DLK INHIBITORS
The present invention provides for compounds of Formula (I) and various embodiments thereof, and compositions comprising compounds of Formula (I) and various embodiments thereof. (I) In compounds of Formula I, the groups R1, R2, R3, R4, R5, R6 and R7 have the meaning as described herein. The present invention also provides for methods of using compounds of Formula I and compositions comprising compounds of Formula (I) as DLK inhibitors and for treating neurodegeneration diseases and disorders.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 89364-31-8, and how the biochemistry of the body works.Recommanded Product: Tetrahydrofuran-3-carboxylic acid
Reference£º
Tetrahydrofuran – Wikipedia,
Tetrahydrofuran | (CH2)3CH2O – PubChem